|
1
|
Nelson WG, De Marzo AM and Isaacs WB:
Prostate cancer. N Engl J Med. 349:366–381. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bubendorf L, Schöpfer A, Wagner U, Sauter
G, Moch H, Willi N, Gasser TC and Mihatsch MJ: Metastatic patterns
of prostate cancer: An autopsy study of 1,589 patients. Hum Pathol.
31:578–583. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ell B and Kang Y: SnapShot: Bone
metastasis. Cell. 151:690–690 e691. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mohammad KS, Chen CG, Balooch G, Stebbins
E, McKenna CR, Davis H, Niewolna M, Peng XH, Nguyen DH,
Ionova-Martin SS, et al: Pharmacologic inhibition of the TGF-beta
type I receptor kinase has anabolic and anti-catabolic effects on
bone. PLoS One. 4:e52752009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Siegel PM and Massagué J: Cytostatic and
apoptotic actions of TGF-beta in homeostasis and cancer. Nat Rev
Cancer. 3:807–821. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jakowlew SB: Transforming growth
factor-beta in cancer and metastasis. Cancer Metastasis Rev.
25:435–457. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Javelaud D, Mohammad KS, McKenna CR,
Fournier P, Luciani F, Niewolna M, André J, Delmas V, Larue L,
Guise TA, et al: Stable overexpression of Smad7 in human melanoma
cells impairs bone metastasis. Cancer Res. 67:2317–2324. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yin JJ, Selander K, Chirgwin JM, Dallas M,
Grubbs BG, Wieser R, Massagué J, Mundy GR and Guise TA: TGF-beta
signaling blockade inhibits PTHrP secretion by breast cancer cells
and bone metastases development. J Clin Invest. 103:197–206. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hu Z, Gupta J, Zhang Z, Gerseny H, Berg A,
Chen YJ, Zhang Z, Du H, Brendler CB, Xiao X, et al: Systemic
delivery of oncolytic adenoviruses targeting transforming growth
factor-β inhibits established bone metastasis in a prostate cancer
mouse model. Hum Gene Ther. 23:871–882. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wan X, Li ZG, Yingling JM, Yang J,
Starbuck MW, Ravoori MK, Kundra V, Vazquez E and Navone NM: Effect
of transforming growth factor beta (TGF-β) receptor I kinase
inhibitor on prostate cancer bone growth. Bone. 50:695–703. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Juárez P and Guise TA: TGF-β in cancer and
bone: Implications for treatment of bone metastases. Bone.
48:23–29. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fournier PG, Juárez P, Jiang G, Clines GA,
Niewolna M, Kim HS, Walton HW, Peng XH, Liu Y, Mohammad KS, et al:
The TGF-β signaling regulator PMEPA1 suppresses prostate cancer
metastases to bone. Cancer Cell. 27:809–821. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ventura A and Jacks T: MicroRNAs and
cancer: Short RNAs go a long way. Cell. 136:586–591. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Khew-Goodall Y and Goodall GJ:
Myc-modulated miR-9 makes more metastases. Nat Cell Biol.
12:209–211. 2010.PubMed/NCBI
|
|
15
|
Baranwal S and Alahari SK: miRNA control
of tumor cell invasion and metastasis. Int J Cancer. 126:1283–1290.
2010.PubMed/NCBI
|
|
16
|
Garzon R, Calin GA and Croce CM: MicroRNAs
in cancer. Annu Rev Med. 60:167–179. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang X, Liu J, Zang D, Wu S, Liu A, Zhu
J, Wu G, Li J and Jiang L: Upregulation of miR-572
transcriptionally suppresses SOCS1 and p21 and contributes to human
ovarian cancer progression. Oncotarget. 6:15180–15193. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hahn WC, Dessain SK, Brooks MW, King JE,
Elenbaas B, Sabatini DM, DeCaprio JA and Weinberg RA: Enumeration
of the simian virus 40 early region elements necessary for human
cell transformation. Mol Cell Biol. 22:2111–2123. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ren D, Lin B, Zhang X, Peng Y, Ye Z, Ma Y,
Liang Y, Cao L, Li X, Li R, et al: Maintenance of cancer stemness
by miR-196b-5p contributes to chemoresistance of colorectal cancer
cells via activating STAT3 signaling pathway. Oncotarget.
8:49807–49823. 2017.PubMed/NCBI
|
|
20
|
Ma L, Young J, Prabhala H, Pan E, Mestdagh
P, Muth D, Teruya-Feldstein J, Reinhardt F, Onder TT, Valastyan S,
et al: miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin
and cancer metastasis. Nat Cell Biol. 12:247–256. 2010.PubMed/NCBI
|
|
21
|
Colden M, Dar AA, Saini S, Dahiya PV,
Shahryari V, Yamamura S, Tanaka Y, Stein G, Dahiya R and Majid S:
MicroRNA-466 inhibits tumor growth and bone metastasis in prostate
cancer by direct regulation of osteogenic transcription factor
RUNX2. Cell Death Dis. 8:e25722017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Siu MK, Tsai YC, Chang YS, Yin JJ, Suau F,
Chen WY and Liu YN: Transforming growth factor-β promotes prostate
bone metastasis through induction of microRNA-96 and activation of
the mTOR pathway. Oncogene. 34:4767–4776. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ren D, Wang M, Guo W, Zhao X, Tu X, Huang
S, Zou X and Peng X: Wild-type p53 suppresses the
epithelial-mesenchymal transition and stemness in PC-3 prostate
cancer cells by modulating miR-145. Int J Oncol. 42:1473–1481.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ren D, Wang M, Guo W, Huang S, Wang Z,
Zhao X, Du H, Song L and Peng X: Double-negative feedback loop
between ZEB2 and miR-145 regulates epithelial-mesenchymal
transition and stem cell properties in prostate cancer cells. Cell
Tissue Res. 358:763–778. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Guo W, Ren D, Chen X, Tu X, Huang S, Wang
M, Song L, Zou X and Peng X: HEF1 promotes epithelial mesenchymal
transition and bone invasion in prostate cancer under the
regulation of microRNA-145. J Cell Biochem. 114:1606–1615. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang M, Ren D, Guo W, Huang S, Wang Z, Li
Q, Du H, Song L and Peng X: N-cadherin promotes
epithelial-mesenchymal transition and cancer stem cell-like traits
via ErbB signaling in prostate cancer cells. Int J Oncol.
48:595–606. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang X, Ren D, Guo L, Wang L, Wu S, Lin
C, Ye L, Zhu J, Li J, Song L, et al: Thymosin beta 10 is a key
regulator of tumorigenesis and metastasis and a novel serum marker
in breast cancer. Breast Cancer Res. 19:152017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Huang S, Guo W, Tang Y, Ren D, Zou X and
Peng X: miR-143 and miR-145 inhibit stem cell characteristics of
PC-3 prostate cancer cells. Oncol Rep. 28:1831–1837. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yang M, Burton DW, Geller J, Hillegonds
DJ, Hastings RH, Deftos LJ and Hoffman RM: The bisphosphonate
olpadronate inhibits skeletal prostate cancer progression in a
green fluorescent protein nude mouse model. Clin Cancer Res.
12:2602–2606. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li X, Liu F, Lin B, Luo H, Liu M, Wu J, Li
C, Li R, Zhang X, Zhou K, et al: miR-150 inhibits proliferation and
tumorigenicity via retarding G1/S phase transition in
nasopharyngeal carcinoma. Int J Oncol. 50:1097–1108. 2017.
View Article : Google Scholar :
|
|
31
|
Wang M, Ren D, Guo W, Wang Z, Huang S, Du
H, Song L and Peng X: Loss of miR-100 enhances migration, invasion,
epithelial-mesenchymal transition and stemness properties in
prostate cancer cells through targeting Argonaute 2. Int J Oncol.
45:362–372. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cioffi M, Trabulo SM, Sanchez-Ripoll Y,
Miranda-Lorenzo I, Lonardo E, Dorado J, Vieira C Reis, Ramirez JC,
Hidalgo M, Aicher A, et al: The miR-17-92 cluster counteracts
quiescence and chemoresistance in a distinct subpopulation of
pancreatic cancer stem cells. Gut. 64:1936–1948. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kang Y, He W, Tulley S, Gupta GP,
Serganova I, Chen CR, Manova-Todorova K, Blasberg R, Gerald WL and
Massagué J: Breast cancer bone metastasis mediated by the Smad
tumor suppressor pathway. Proc Natl Acad Sci USA. 102:pp.
13909–13914. 2005; View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sand M, Hessam S, Amur S, Skrygan M,
Bromba M, Stockfleth E, Gambichler T and Bechara FG: Expression of
oncogenic miR-17-92 and tumor suppressive miR-143-145 clusters in
basal cell carcinoma and cutaneous squamous cell carcinoma. J
Dermatol Sci. 86:142–148. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhu M, Huang Z, Zhu D, Zhou X, Shan X, Qi
LW, Wu L, Cheng W, Zhu J, Zhang L, et al: A panel of microRNA
signature in serum for colorectal cancer diagnosis. Oncotarget.
8:17081–17091. 2017.PubMed/NCBI
|
|
36
|
Zhang X, Chen Y, Zhao P, Zang L, Zhang Z
and Wang X: MicroRNA-19a functions as an oncogene by regulating
PTEN/AKT/pAKT pathway in myeloma. Leuk Lymphoma. 58:932–940. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Pan Y, Guo Y, Luo Y, Li H and Xu Y:
MicroRNA expression profiling of Chinese follicular lymphoma by
microarray: A preliminary study. Int Immunopharmacol. 39:41–47.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ibarrola-Villava M, Llorca-Cardeñosa MJ,
Tarazona N, Mongort C, Fleitas T, Perez-Fidalgo JA, Roselló S,
Navarro S, Ribas G and Cervantes A: Deregulation of ARID1A, CDH1,
cMET and PIK3CA and target-related microRNA expression in gastric
cancer. Oncotarget. 6:26935–26945. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zheng G, Du L, Yang X, Zhang X, Wang L,
Yang Y, Li J and Wang C: Serum microRNA panel as biomarkers for
early diagnosis of colorectal adenocarcinoma. Br J Cancer.
111:1985–1992. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wu Q, Guo L, Jiang F, Li L, Li Z and Chen
F: Analysis of the miRNA-mRNA-lncRNA networks in ER+ and ER- breast
cancer cell lines. J Cell Mol Med. 19:2874–2887. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Balci S, Ayaz L, Gorur A, Yaroglu H
Yildirim, Akbayir S, Unal N Dogruer, Bulut B, Tursen U and Tamer L:
microRNA profiling for early detection of nonmelanoma skin cancer.
Clin Exp Dermatol. 41:346–351. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Leung CM, Chen TW, Li SC, Ho MR, Hu LY,
Liu WS, Wu TT, Hsu PC, Chang HT and Tsai KW: MicroRNA expression
profiles in human breast cancer cells after multifraction and
single-dose radiation treatment. Oncol Rep. 31:2147–2156. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zhi F, Shao N, Wang R, Deng D, Xue L, Wang
Q, Zhang Y, Shi Y, Xia X, Wang S, et al: Identification of 9 serum
microRNAs as potential noninvasive biomarkers of human astrocytoma.
Neuro-oncol. 17:383–391. 2015. View Article : Google Scholar : PubMed/NCBI
|
